Following on from the email update you received in March regarding the delay to the use of tumour necrosis factor alpha (TNF a) inhibitors (adalimumab, and infliximab [review]) for Crohn's disease appraisal, we can now confirm that the first Appraisal Committee meeting for will be held on 20 August 2008.

You can expect a set of papers for consultation during September 2008.

We will keep you informed of if there are any other changes. If you have any queries, please contact me at eloise.saile@nice.org.uk or by phone: 020 7045 2243.

Yours sincerely,                                        

Eloise Saile